{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:13:16Z","timestamp":1778256796176,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Sygeforsikringen \u201cDanmark\u201d","award":["2021-0128"],"award-info":[{"award-number":["2021-0128"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphomas occur less frequently in women than men, but the causes remain unclear. Given the immunomodulatory potential of female hormones, hormonal contraceptive use could influence lymphoma risk, yet existing research is inconclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the relationship between contemporary hormonal contraceptive use and lymphoma risk in a nationwide Danish cohort of women aged 15-49\u2009years (1995-2021). Women with prior cancer, hysterectomy, oophorectomy, or sterilization were excluded. Data on hormonal contraceptive use, lymphomas, and confounders were retrieved from national registries. Incidence rate ratios with 95% confidence intervals (CIs) were estimated for any hormonal contraceptive use and lymphoma risk, including lymphoma subtypes, contraceptive types, duration of use, and time since last use. All statistical tests were 2-sided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 24.5 million person-years of follow-up, 1777 lymphomas (686 Hodgkin, 1091 non-Hodgkin) occurred among 1\u200a957\u200a490 women. Ever-using hormonal contraception was associated with reduced lymphoma risk (incidence rate ratio = 0.84, 95% CI = 0.75 to 0.94), with similar incidence rate ratios across lymphoma types. This was driven by current or recent use of both combined products (incidence rate ratio = 0.80, 95% CI = 0.70 to 0.91) and progestin-only products (incidence rate ratio = 0.81, 95% CI = 0.67 to 0.97), especially oral combined and nonoral progestin-only products. Risk decreased with longer use, with the lowest risk for use more than 10\u2009years (incidence rate ratio = 0.53, 95% CI = 0.33 to 0.85), but no long-term sustained protective effect was seen after cessation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings indicate that hormonal contraceptive use may have a role in lymphoma etiology and confer protective effects, underscoring the need to explore hormonal pathways in a preventive and therapeutic context.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djaf371","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:52:42Z","timestamp":1766062362000},"page":"877-883","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal contraception and lymphoma risk in Danish women aged 15\u201349 years: a nationwide cohort study"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-1981","authenticated-orcid":false,"given":"Caroline H","family":"Hemmingsen","sequence":"first","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute , Copenhagen,","place":["Denmark"]},{"name":"Cancer and Medicine, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-2569","authenticated-orcid":false,"given":"Lina S","family":"M\u00f8rch","sequence":"additional","affiliation":[{"name":"Cancer and Medicine, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8644-0822","authenticated-orcid":false,"given":"Jasmin","family":"Arvedsen","sequence":"additional","affiliation":[{"name":"Cancer and Medicine, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8970-7226","authenticated-orcid":false,"given":"Emma O","family":"Dahl","sequence":"additional","affiliation":[{"name":"Cancer and Medicine, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4549-8271","authenticated-orcid":false,"given":"Amani","family":"Meaidi","sequence":"additional","affiliation":[{"name":"Cancer and Medicine, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-6798","authenticated-orcid":false,"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[{"name":"Hematology, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-9242","authenticated-orcid":false,"given":"Marie","family":"Hargreave","sequence":"additional","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-1398","authenticated-orcid":false,"given":"Susanne K","family":"Kjaer","sequence":"additional","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute , Copenhagen,","place":["Denmark"]},{"name":"Department of Gynecology, Copenhagen University Hospital Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2026050811433590300_djaf371-B1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026050811433590300_djaf371-B2","first-page":"226","article-title":"Etiology of non-Hodgkin lymphoma: a review from epidemiologic studies","volume":"2","author":"Luo","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"2026050811433590300_djaf371-B3","volume-title":"Lymphoma","author":"Jamil","year":"2025"},{"key":"2026050811433590300_djaf371-B4","first-page":"23","article-title":"Sex differences in lymphoma incidence and mortality by subtype: a population-based study","volume":"98","author":"Radkiewicz","year":"2023","journal-title":"Am J Hematol"},{"key":"2026050811433590300_djaf371-B5","first-page":"275","article-title":"Hormonal contraception and the development of autoimmunity: a review of the literature","volume":"84","author":"Williams","year":"2017","journal-title":"Linacre Q"},{"key":"2026050811433590300_djaf371-B6","first-page":"528","article-title":"The emerging role of estrogen in B cell malignancies","volume":"58","author":"Ladikou","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"2026050811433590300_djaf371-B7","first-page":"20718","article-title":"Inhibition of estrogen biosynthesis enhances lymphoma growth in mice","volume":"7","author":"Talaber","year":"2016","journal-title":"Oncotarget"},{"key":"2026050811433590300_djaf371-B8","first-page":"1381","article-title":"Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin\u2019s lymphoma in women","volume":"19","author":"Nelson","year":"2001","journal-title":"J Clin Oncol"},{"key":"2026050811433590300_djaf371-B9","first-page":"1630","article-title":"Oral contraceptive use and risks of cancer in the NIH-AARP diet and health study","volume":"187","author":"Michels","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2026050811433590300_djaf371-B10","first-page":"274","article-title":"Reproductive factors, exogenous hormone use, and risk of B-cell non-hodgkin lymphoma in a cohort of women from the european prospective investigation into cancer and nutrition","volume":"188","author":"Costas","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2026050811433590300_djaf371-B11","first-page":"292","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2026050811433590300_djaf371-B12","first-page":"2362","article-title":"Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies","volume":"23","author":"Kane","year":"2012","journal-title":"Ann Oncol"},{"key":"2026050811433590300_djaf371-B13","first-page":"974","article-title":"Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study","volume":"129","author":"Lu","year":"2011","journal-title":"Int J Cancer"},{"key":"2026050811433590300_djaf371-B14","first-page":"553","article-title":"Reproductive factors in Hodgkin\u2019s disease in women","volume":"158","author":"Glaser","year":"2003","journal-title":"Am J Epidemiol"},{"key":"2026050811433590300_djaf371-B15","first-page":"A08200599","article-title":"Hormonal contraceptive use in Denmark 2010-2019","volume":"68","author":"Kristensen","year":"2021","journal-title":"Dan Med J"},{"key":"2026050811433590300_djaf371-B16","first-page":"145","article-title":"The current status of oral contraceptives: progress and recent innovations","volume":"34","author":"Golobof","year":"2016","journal-title":"Semin Reprod Med"},{"key":"2026050811433590300_djaf371-B17","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"1999"},{"key":"2026050811433590300_djaf371-B18","first-page":"541","article-title":"The danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2026050811433590300_djaf371-B19","first-page":"38","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026050811433590300_djaf371-B20","first-page":"42","article-title":"The Danish cancer registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026050811433590300_djaf371-B21","first-page":"2737","article-title":"Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort","volume":"124","author":"Morton","year":"2009","journal-title":"Int J Cancer"},{"key":"2026050811433590300_djaf371-B22","first-page":"109474","article-title":"Antitumor progestins activity: cytostatic effect and immune response","volume":"210","author":"Pavlik","year":"2024","journal-title":"Steroids"},{"key":"2026050811433590300_djaf371-B23","author":"United Nations Department of Economic and Social Affairs"},{"key":"2026050811433590300_djaf371-B24","first-page":"745","volume-title":"Cancer Epidemiology and Prevention","author":"Hjalgrim","year":"2017","edition":"4th ed"},{"key":"2026050811433590300_djaf371-B25","first-page":"767","volume-title":"Cancer Epidemiology and Prevention","author":"Cerhan","year":"2017","edition":"4th ed"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf371\/66107655\/djaf371.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/5\/877\/66107655\/djaf371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/5\/877\/66107655\/djaf371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:43:43Z","timestamp":1778255023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/5\/877\/8402142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,12,22]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf371","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,12,22]]}}}